Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
Réseau européen pour l'évaluation des technologies de la santé (EUnetHTA), publié en ligne en janvier 2019
Cette évaluation collaborative concernant les tests de la protéine C réactive (CRP) en point-of-care (POC) a pour objectif d'orienter la prescription d'antibiotiques dans le cadre de soins primaires pour les infections aiguës des voies respiratoires (IVR). L'évaluation visait à répondre à trois questions en effectuant trois examens s...
Test en biologie délocalisée pour la protéine C réactive afin d'orienter la prescription d'antibiotiques dans le cadre de soins primaires pour les inf...
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward et Ann Van den Bruel
BMJ Open, 2019
Cet examen avait pour objectif de rassembler toutes les preuves disponibles sur l'impact des tests en point-of-care (POCT) pour la protéine C réactive (CRP) sur les résultats pertinents chez les enfants et les adultes dans les soins ambulatoires. Au total, 11 essais contrôlés randomisés et 8 é...
Impact des tests en biologie délocalisée pour la CRP dans les soins ambulatoires : examen systématique et méta-analyse
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Health Information and Quality Authority (HIQA), published online April 2019This health technology assessment (HTA) aimed to establish the clinical and cost-effectiveness of CRP POCT, plus examined the organisational implications of the potential introduction of the technology into primary care. A summary of key findings is provided below:
Health Technology Assessment of CRP POCT to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with approximately 800 attendees from across approximately 50 countries and more than 250 speakers.
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with ~800 attendees from across ~50 countries and more than 250 speakers. This year, on 8–9 October 2020, myPOCacademy hosted a live seminar led by Professor Jonathan Cooke from Imperial College London and the University of Manchester (UK), now exclusively available to watch in full here.
Hear how point-of-care testing may aid in reducing antimicrobial resistance during the COVID-19 pandemic
The ERS international congress on 7–9 September 2020 delivered the latest innovations in respiratory medicine, plus offered an opportunity to interact and connect with the respiratory community virtually.
European Respiratory Society virtual international congress 2020
Check out the on-demand symposium recording from the European Respiratory Society congress 2020 by clicking here. Learn how C-reactive protein (CRP) point-of-care testing can be a valuable diagnostic and clinical decision-making tool in relation to COVID-19, and how it may also inform antibiotic prescribing for acutely exacerbated chronic obstructive pulmonary disease (COPD) patients.
Learn about the value of CRP point-of-care testing for COPD and antimicrobial resistance in the context of COVID-19
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 9 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
Hear expert opinion on the use of CRP point-of-care testing for COVID-19 management and reduction of antimicrobial resistance
en
Accéder maintenant
Contenu certifié
Plus de résultats
By using this site, you agree with our use of cookies.
